RxDoctor Payments Data

Shane Brogan, MD

Anesthesiology · Salt Lake City, UTNPI 1851481436

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $88,455 of the $103,683 with a category attached, or 85.3%. Medtronic accounts for 97.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $47,094 and has fallen 99.9% since, to $59 in 2024. Among anesthesiology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$103,683in general payments, 2019–2025

Across 127 payments — averaging $816.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$101K
  • Roche Products Limited$2K
  • Abbott$501
  • Stryker$104
  • SPR Therapeutics, Inc$73
  • Saluda Medical Americas, Inc.$15
$2,065in research payments, 2019–2025

Across 2 payments — averaging $1032.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$2K

What the payments were for

  • Consulting fees$2,0252%
  • Speaking & faculty fees$88,45585%
  • Travel & lodging$10,12410%
  • Food & beverage$3,0803%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)115$100,965
Roche Products Limited1$2,025
Abbott6$501
Stryker3$104
SPR Therapeutics, Inc1$73
Saluda Medical Americas, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$103,683 in reported general payments places this provider in the 95th percentile of 510 anesthesiology providers in Utah.

See all anesthesiology providers in Utah

Medicare billing

Part B allowed, 2024
$51,551
Medicare patients
137
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl29$3,002
Naloxone Hcl35$2,288
Pregabalin14$585
Gabapentin28$560
Oxycodone Hcl33$549
Morphine Sulfate ErMorphine Sulfate18$496
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$366
Diclofenac Sodium12$313
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$304
Duloxetine Hcl29$204
Trazodone Hcl13$37

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →